NGNg Chong Guan

Ng Chong Guan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ng Chong Guan has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Nor Zuraida Zainal

    5 shared publications
  • Ahmad Hatim Sulaiman

    Department of Psychological Medicine, University Malaya Medical Centre, Lembah Pantai, 50603 Kuala Lumpur, Malaysia

    4 shared publications
  • Marco Pm Boks

    Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands

    4 shared publications
  • Anne Yee

    Monash University Malaysia

    3 shared publications
  • Hatta Sidi

    Drs. Sidi, MMED, Jaafar, MMED, Midi, MMED, Department of Psychiatry, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia. Dr. Asmidar, MMED, Department of Psychiatry and Mental Health, Hospital Melaka, Melaka, Malaysia. Dr. Seng, FRACGP, Department of Family Medicine, International Medical University, Kuala Lumpur, Malaysia. Dr. Guan, MPM, Department of Psychological Medicine, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia

    3 shared publications
  • Niek J. de Wit

    Julius Centre for Health Sciences and Primary Care, University Medical Centre, Utrecht, the Netherlands

    3 shared publications

Latest Publications

  • Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine

    by Hatta Sidi, Duni Asmidar, Loh Huai Seng, Nik Ruzyanei Nik Jaafar, Marhani Midi, Ng Chong Guan

    Objectives The current study compares the risk of sexual pain in depressed female patients in remission between those who were treated with Escitalopram and Fluoxetine. The associated factors were also examined. Methods This is a cross-sectional study involved 112 depressed female patients (56 treated with Escitalopram and 56 treated with Fluoxetine) who were in remission (as defined by Diagnostic and Statistical Manual-IV (DSM-IV) in the past 2 months and Montgomery-Asberg Depression Rating Scale (MADRS) score of ≤ 10) from the psychiatric clinic, University Kebangsaan Malaysia Medical Centre (UKMMC). They were interviewed using Structured Clinical Interview for DSM-IV (SCID). Hypoactive sexual desire was assessed using the Pain subscale of Malay Version of the Female Sexual Function Index (MVFSFI). Results The results show that risk of sexual pain was relatively low (16.07% for all patients), with no statistical significant between the two groups (17.86% for fluoxetine group, 14.29% for escitalopram group). Older age (adjusted odds ratio = 1.524, 95% CI = 1.199, 1.938) was the only factor significantly associated with sexual pain disorder. Conclusions There should not be any barrier when continuing the use of escitalopram or fluoxetine as antidepressants amongst the female patients.

  • Open Access

    Comparison of Psychotropic Prescriptions between Oncology and Cardiology Inpatients: Result from a Pharmacy Database in a Teaching Hospital in Malaysia

    by Chong Guan Ng, Salina Mohamed, Tai Yi Wern, Azwa Haris, Nor Zuraida Zainal, Ahmad Hatim Sulaim

    To examine the prescription rates in cancer patients of three common psychotropic drugs: anxiolytic/ hypnotic, antidepressant and antipsychotic. In this retrospective cohort study, data were extracted from the pharmacy database of University Malaya Medical Center (UMMC) responsible for dispensing records of patients stored in the pharmacy's Medication Management and Use System (Ascribe). We analyzed the use of psychotropics in patients from the oncology ward and cardiology from 2008 to 2012. Odds ratios (ORs) were adjusted for age, gender and ethnicity. A total of 3,345 oncology patients and 8,980 cardiology patients were included. Oncology patients were significantly more often prescribed psychotropic drugs (adjusted OR: anxiolytic/hypnotic=5.55 (CI: 4.64-6.63); antidepressants=6.08 (CI: 4.83-7.64) and antipsychotics=5.41 (CI: 4.17-7.02). Non-Malay female cancer patients were at significantly higher risk of anxiolytic/hypnotic use. Psychotropic drugs prescription is common in cancer patients. Anxiolytic/hypnotic prescription rates are significantly higher in non-Malay female patients in Malaysia.


    • 1 May 2014
      • Vol. 21  (3) , 62-70

    Validation of Malay Version of Snaith-Hamilton Pleasure Scale: Comparison between Depressed Patients and Healthy Subjects at an Out-Patient Clinic in Malaysia.

    by Chong Guan Ng, Soo Cheng Chin, Anne Hway Ann Yee, Huai Seng Loh, Ahmad Hatim Sulaiman, Wong Sherianne Sook Kuan, Mohamed Hussain Habil

    The Snaith-Hamilton Pleasure Scale (SHAPS) is a self-assessment scale designed to evaluate anhedonia in various psychiatric disorders. In order to facilitate its use in Malaysian settings, our current study aimed to examine the validity of a Malay-translated version of the SHAPS (SHAPS-M). In this cross-sectional study, a total of 44 depressed patients and 82 healthy subjects were recruited from a university out-patient clinic. All participants were given both the Malay and English versions of the SHAPS, Fawcett-Clark Pleasure Scale (FCPS), General Health Questionnaire 12 (GHQ-12), and the Beck Depression Inventory (BDI) to assess their hedonic state, general mental health condition and levels of depression. The results showed that the SHAPS-M has impressive internal consistency (α = 0.96), concurrent validity and good parallel-form reliability (intraclass coefficient, ICC = 0.65). In addition to demonstrating good psychometric properties, the SHAPS-M is easy to administer. Therefore, it is a valid, reliable, and suitable questionnaire for assessing anhedonia among depressed patients in Malaysia.


  • Open Access

    Methylphenidate for the Treatment of Erectile Dysfunction Induced By Long Acting Injectable Paliperidone Palmitate: A Case Report

    by Ng Chong Guan, Koh Ong Hui, Jesjeet Singh Gill

    Erectile dysfunction is one of the common sexual adverse effects encountered in male patients treated with antipsychotics. It is associated with prolactin secretion secondary to dopamine antagonism by the antipsychotics. Methylphenidate is a psychostimulant that inhibits the reuptake of dopamine. In this case, we report a 42 year old schizophrenic male, who developed erectile dysfunction after administration of a long acting injectable antipsychotic, namely paliperidone palmitate. The erectile dysfunction did not respond to sildenafil but recovered with the treatment of methylphenidate 10mg. The current finding suggests that clinicians should be aware of the possible emergence of erectile dysfunction among patients on long acting injectable antipsychotics. Methylphenidate may be an alternative treatment option for erectile dysfunction induced by antipsychotics.


  • Open Access

    Risk and associated factors of female sexual orgasmic disorder in women with hypertension in Malaysia

    by Rozimah Abdul Latif, Rosediani Muhamad, Sharmilla Kanagasundram, Hatta Sidi, Nik Ruzyanei Nik Jaafar, Marhani Midin, Srijit Das, Chong Guan Ng

    Introduction: The objective of this study was to examine the risk of female sexual orgasmic disorder among a group of women with hypertension in Malaysia. The associated factors were also examined.Methods: This cross‐sectional study involved 348 hypertensive women attending the primary care or hypertension clinic in a teaching hospital in Malaysia. Female sexual orgasmic disorder was assessed using the Orgasmic subscale of the Malay Version of the Female Sexual Function Index (MVFSFI). Basic socio‐demographic data of the subjects was collected using a predesigned questionnaire. Medical records were reviewed to gather patients' medical information.Results: The risk of female sexual orgasmic disorder among hypertensive women was 14.1%. Univariate analysis found that older age, longer duration of marriage, lower educational level, and menopause were associated with higher risk of female sexual orgasmic disorder. These factors were not significant in multivariate analysis.Discussion: The risk of female sexual orgasmic disorder was relatively low in Malaysian women with hypertension. No risk factors were associated with female sexual orgasmic disorder in the current study.


  • Factorial Validity and Reliability of the Malaysian Simplified Chinese Version of Multidimensional Scale of Perceived Social Support (MSPSS-SCV) Among a Group of University Students

    by Ng Chong Guan, Loh Huai Seng, Anne Yee Hway Ann, Koh Ong Hui

    This study was aimed at validating the simplified Chinese version of the Multidimensional Scale of Perceived Support (MSPSS-SCV) among a group of medical and dental students in University Malaya. Two hundred and two students who took part in this study were given the MSPSS-SCV, the Medical Outcome Study social support survey, the Malay version of the Beck Depression Inventory, the Malay version of the General Health Questionnaire, and the English version of the MSPSS. After 1 week, these students were again required to complete the MSPSS-SCV but with the item sequences shuffled. This scale displayed excellent internal consistency (Cronbach’s α = .924), high test–retest reliability (.71), parallel form reliability (.92; Spearman’s ρ, P < .01), and validity. In conclusion, the MSPSS-SCV demonstrated sound psychometric properties in measuring social support among a group of medical and dental students. It could therefore be used as a simple screening tool among young educated Malaysian adolescents.


  • The prevalence and correlates of alcohol use disorder amongst bipolar patients in a hospital setting, Malaysia

    by Hway Ann Yee, Huai Seng Loh, Chong Guan Ng

    Objective. To determine the prevalence of alcohol-use disorder and associated correlates amongst bipolar patients in a university hospital in Malaysia. Methods. In this cross-sectional study, a total of 121 bipolar disorder patients were included. Their alcohol use disorders were assessed with the Mini International Neuropsychiatric Interview (plus version) and the Addiction Severity Index-Lite-Clinical Factors version. The number of lifetime hospitalizations and the survival days (the number of days between the last discharge and the most current readmission) were calculated. Results. The prevalence of alcohol-use disorder amongst bipolar patients was 18.2%. Indian ethnicity was the only demographic factor that was statistically associated with alcohol-use disorder (p < 0.03). Those with alcohol-use disorder had a significantly higher rate of suicidal attempt (p < 0.01) and more psychiatric hospitalizations than those without after adjusting for gender, race, employment status, education level and duration of illness (p < 0.01). Conclusions. The prevalence of alcohol-use disorder was low in bipolar patients but highin the general population of Malaysia. Since alcohol-use disorder, as well as the potential interactions with the course of the disorder, is highly prevalent amongst bipolar patients, alcohol use should be addressed in these patients.


  • Diagnostic Criteria for Major Depressive Disorder in Cancer Patients: A Review

    by Ng Chong Guan, Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Marco P. M. Boks, Niek J. de Wit

    Objectives: The lack of universal criteria makes diagnosing clinical depression in cancer patients a challenging task. We therefore review the current state of evidence regarding such diagnostic criteria for major depressive disorder in cancer patients. Methods: We conducted a literature search for studies which compare two or more sets of diagnostic criteria for depression in cancer patients. The results were extracted and summarized. Results: Three original studies were included in this review. One study supported the use of substitutive (Endicott) criteria. Another study showed the potential of an increased threshold approach and one had no conclusive findings. Conclusion: There was no standard reference test and precise definition of alternative criteria in these studies. There are no recognized diagnostic criteria for depression in cancer patients despite an apparent need for such criteria.


  • Psychiatric comorbidity among terminally ill patients in general practice in the Netherlands: a comparison between patients with cancer and heart failure

    by Chong Guan Ng, Ellen Dijkstra, Hugo Smeets, Marco Pm Boks, Niek J de Wit

    It is unclear whether psychiatric disorders are specifically related to the terminal phase of cancer, or independent of the underlying disease. To investigate the rate of psychiatric comorbidity and psychotropic drugs prescription in terminally ill patients in the GP setting, comparing both patients with terminal cancer and heart failure. Retrospective cohort study using the Utrecht General Practitioner Research Network. Equally-sized groups of patients with terminal cancer and heart failure were randomly selected from the database of four general practices over the years 2005-2009. Psychiatric comorbidities were determined using the International Classification for Primary Care (ICPC) codes and psychotropic drugs prescriptions using the Anatomical Therapeutic Chemical (ATC) Classification System codes. A total of 191 terminally ill patients were included in the study (111 with cancer and 80 with heart failure). The mean age for patients with terminal cancer (70.8 years, standard deviation [SD] = 12.8) was 15 years younger than that of patients with heart failure (85.6 years, SD = 9.2). Half of the terminally ill patients (50.3 %) were prescribed psychotropics, but only 13.6% of them had obtained a psychiatric diagnosis. There were no significant differences in prevalence of psychiatric disease and psychotropic drug prescription between patients with terminal cancer and heart failure. The results demonstrate a high use of psychotropic drugs in terminally ill patients, often in the absence of a formal diagnosis of a psychiatric disorder. The absence of differences between patients with cancer and heart failure suggests that psychiatric diagnoses and increased psychotropic prescriptions are primarily related to the terminal stage of the disease and not to the background of cancer or heart failure.